Bentley Pharmaceuticals (BNT) Q4 2024 Earnings

Screener

Reported February 13, 2025 · Before market open

Revenue$6.0B

EPS$0.08

Next report

Aug 13, 2026 (In 1 week)

Versus estimates

Revenue

Q4 2025$3.1B Q3 2025$3.1B Q2 2025$3.0B Q1 2025$2.4B

Q4 2024$6.0B

Diluted EPS

Q1 2026$0.07 Q4 2025$0.06 Q3 2025$0.06 Q2 2025$0.06 Q1 2025$0.09

Q4 2024$0.08

FAQ

When did Bentley Pharmaceuticals report Q4 2024 earnings?: Bentley Pharmaceuticals (BNT) reported Q4 2024 earnings on February 13, 2025 before market open.
What were Bentley Pharmaceuticals's Q4 2024 revenue and EPS?: Bentley Pharmaceuticals reported revenue of $6.0B and eps of $0.08 for Q4 2024.
How did Bentley Pharmaceuticals's Q4 2024 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 156.5% from $2.3B a year earlier and eps grew 0.0% from $0.08.

Ask the moment Bentley Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk